{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:05:35Z","timestamp":1784333135803,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalimaging.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Imaging"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.clinimag.2022.05.002","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T21:14:02Z","timestamp":1651698842000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Factors associated with radiologic-pathologic discordance in magnetic resonance imaging after neoadjuvant chemotherapy for breast cancer"],"prefix":"10.1016","volume":"89","author":[{"given":"Mi-ri","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinah","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin Ho","family":"Kook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinimag.2022.05.002_bb0005","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/annonc\/mdm201","article-title":"Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006","volume":"18","author":"Kaufmann","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0010","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/cncr.20815","article-title":"Breast conservation after neoadjuvant chemotherapy","volume":"103","author":"Chen","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0015","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1200\/JCO.1998.16.8.2672","article-title":"Effect of preoperative chemotherapy on the outcome of women with operable breast cancer","volume":"16","author":"Fisher","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0020","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1200\/JCO.2007.15.0235","article-title":"Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27","volume":"26","author":"Rastogi","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0025","first-page":"186","article-title":"The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment","volume":"16","author":"Turkbey","year":"2010","journal-title":"Diagn Interv Radiol"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13244-013-0219-y","article-title":"The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review","volume":"4","author":"Lobbes","year":"2013","journal-title":"Insights Imaging"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0035","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/jnci\/djs528","article-title":"Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy","volume":"105","author":"Marinovich","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0040","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.clbc.2016.12.010","article-title":"Role of magnetic resonance imaging in detection of pathologic complete remission in breast cancer patients treated with neoadjuvant chemotherapy: a meta-analysis","volume":"17","author":"Gu","year":"2017","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2019.108701","article-title":"Breast cancer phenotype influences MRI response evaluation after neoadjuvant chemotherapy","volume":"120","author":"Negrao","year":"2019","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0050","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.clbc.2017.07.001","article-title":"Discrepancies between pathological tumor responses and estimations of complete response by magnetic resonance imaging after neoadjuvant chemotherapy differ by breast cancer subtype","volume":"18","author":"Namura","year":"2018","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0055","doi-asserted-by":"crossref","first-page":"197","DOI":"10.21037\/qims.2019.11.16","article-title":"The diagnostic accuracy of magnetic resonance imaging in predicting pathologic complete response after neoadjuvant chemotherapy in patients with different molecular subtypes of breast cancer","volume":"10","author":"Zhang","year":"2020","journal-title":"Quant Imaging Med Surg"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0060","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jss.2017.12.002","article-title":"Prediction of pathological response to neoadjuvant chemotherapy in breast cancer patients by imaging","volume":"225","author":"Kaise","year":"2018","journal-title":"J Surg Res"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/cncr.23130","article-title":"MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy","volume":"112","author":"Chen","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0075","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1007\/s00330-001-1233-x","article-title":"Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy","volume":"12","author":"Rieber","year":"2002","journal-title":"Eur Radiol"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0080","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2325\/jbcs.951","article-title":"Magnetic resonance mammography has limited ability to estimate pathological complete remission after primary chemotherapy or radiofrequency ablation therapy","volume":"14","author":"Nakamura","year":"2007","journal-title":"Breast Cancer"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0085","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1245\/s10434-013-2925-6","article-title":"Analysis of factors that influence the accuracy of magnetic resonance imaging for predicting response after neoadjuvant chemotherapy in locally advanced breast cancer","volume":"20","author":"Ko","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0090","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejrad.2019.06.017","article-title":"Complete response on MR imaging after neoadjuvant chemotherapy in breast cancer patients: factors of radiologic-pathologic discordance","volume":"118","author":"Choi","year":"2019","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0095","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1245\/s10434-009-0441-5","article-title":"Residual breast cancer diagnosed by MRI in patients receiving neoadjuvant chemotherapy with and without bevacizumab","volume":"16","author":"Bahri","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0100","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1245\/s10434-014-4122-7","article-title":"Impact of multifocal or multicentric disease on surgery and locoregional, distant and overall survival of 6,134 breast cancer patients treated with neoadjuvant chemotherapy","volume":"22","author":"Ataseven","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0105","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.crad.2006.07.004","article-title":"MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy","volume":"61","author":"Belli","year":"2006","journal-title":"Clin Radiol"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0110","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2214\/ajr.179.5.1791193","article-title":"Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy","volume":"179","author":"Partridge","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0115","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.ejso.2004.07.024","article-title":"Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer","volume":"30","author":"Denis","year":"2004","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1023\/B:BREA.0000010700.11092.f4","article-title":"Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging","volume":"83","author":"Martincich","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0125","doi-asserted-by":"crossref","first-page":"868","DOI":"10.2214\/ajr.184.3.01840868","article-title":"Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer","volume":"184","author":"Yeh","year":"2005","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0130","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1080\/02841860701373587","article-title":"Accuracy of MRI for estimating residual tumor size after neoadjuvant chemotherapy in locally advanced breast cancer: relation to response patterns on MRI","volume":"46","author":"Kim","year":"2007","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0135","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1148\/radiol.2542090405","article-title":"Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging\u2013comparison with contrast-enhanced MR imaging and pathologic findings","volume":"254","author":"Woodhams","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0140","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/annonc\/mdn683","article-title":"Age and HER2 expression status affect MRI accuracy in predicting residual tumor extent after neo-adjuvant systemic treatment","volume":"20","author":"Moon","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0145","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1158\/1078-0432.CCR-03-0695","article-title":"HER-2 gene amplification correlates with higher levels of angiogenesis and lower levels of hypoxia in primary breast tumors","volume":"10","author":"Blackwell","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0150","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/bjc.1997.333","article-title":"Is a histological section representative of whole tumour vascularity in breast cancer?","volume":"76","author":"Martin","year":"1997","journal-title":"Br J Cancer"},{"issue":"641","key":"10.1016\/j.clinimag.2022.05.002_bb0155","first-page":"e19","article-title":"Preoperative evaluation of mammographic microcalcifications after neoadjuvant chemotherapy for breast cancer","volume":"75","author":"Kim","year":"2020","journal-title":"Clin Radiol"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0160","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1148\/radiol.2018170960","article-title":"Human epidermal growth factor 2-positive breast cancer with mammographic microcalcification: relationship to pathologic complete response after neoadjuvant chemotherapy","volume":"288","author":"Mazari","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0165","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2214\/AJR.09.3908","article-title":"Accuracy of MRI in prediction of pathologic complete remission in breast cancer after preoperative therapy: a meta-analysis","volume":"195","author":"Yuan","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0170","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3892\/ol.2012.1004","article-title":"Analysis of complete response by MRI following neoadjuvant chemotherapy predicts pathological tumor responses differently for molecular subtypes of breast cancer","volume":"5","author":"Hayashi","year":"2013","journal-title":"Oncol Lett"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0175","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1590\/0100-3984.2018.0149","article-title":"Accuracy of breast magnetic resonance imaging in evaluating the response to neoadjuvant chemotherapy: a study of 310 cases at a cancer center","volume":"52","author":"Negrao","year":"2019","journal-title":"Radiol Bras"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0180","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20140142","article-title":"Prediction of pathological complete response of breast cancer patients undergoing neoadjuvant chemotherapy: usefulness of breast MRI computer-aided detection","volume":"87","author":"Kim","year":"2014","journal-title":"Br J Radiol"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0185","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.diii.2018.09.001","article-title":"Enhancement of breast cancer on pre-treatment dynamic contrast-enhanced MRI using computer-aided detection is associated with response to neo-adjuvant chemotherapy","volume":"99","author":"Chamming's","year":"2018","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0190","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1148\/radiol.10100454","article-title":"Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast","volume":"258","author":"Berg","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0195","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/S0140-6736(11)61350-0","article-title":"MRI for breast cancer screening, diagnosis, and treatment","volume":"378","author":"Morrow","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.clinimag.2022.05.002_bb0200","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/nbm.1273","article-title":"Dynamic contrast-enhanced MRI in the diagnosis and management of breast cancer","volume":"22","author":"Turnbull","year":"2009","journal-title":"NMR Biomed"}],"container-title":["Clinical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707122001280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707122001280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:48:55Z","timestamp":1760269735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899707122001280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":39,"alternative-id":["S0899707122001280"],"URL":"https:\/\/doi.org\/10.1016\/j.clinimag.2022.05.002","relation":{},"ISSN":["0899-7071"],"issn-type":[{"value":"0899-7071","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with radiologic-pathologic discordance in magnetic resonance imaging after neoadjuvant chemotherapy for breast cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinimag.2022.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}